New Scientist Colab Podcasts

New Scientist

Podcasts for the insatiably curious, produced by New Scientist in collaboration with carefully selected external parties. Hosted on Acast. See acast.com/privacy for more information.

  1. 1D AGO

    How UK and Spanish scientists are reimagining the future of green pharma

    The production of medicines is a high-stakes industry where efficiency and environmental impact often collide.  Given that the pharmaceutical industry is one of society’s biggest polluters, solving this challenge requires massive, cross-continent collaboration to spark real change. In this episode, we explore how some of the UK and Europe’s premier research institutes and pharmaceutical companies have joined forces to pioneer "greener" production methods. This work is funded by Horizon Europe, the European Union’s flagship €96 billion research and innovation funding programme. We visit Barcelona to talk to Dr Laura Rodriguez and Dr Andrés Cruz from IRIS Technology Solutions. They share how their collaboration with UK research teams has yielded impressive results—and why the partnership itself has been a key factor in the success. This is a New Scientist CoLab production, sponsored by the UK Government. For more information and to find a UK partner for your next Horizon Europe bid, click here. Your host is James Randerson. Read more about the UK-Spanish partnerships solving pharma’s toughest challenges. Learn more about your ad choices. Visit megaphone.fm/adchoices

    28 min
  2. Discover Vanguard, the future of ocean research

    11/20/2025

    Discover Vanguard, the future of ocean research

    Imagine humans one day living and working on the ocean floor. Aquanauts in subsea habitats, surrounded by ocean creatures, discovering new secrets about our planet. This might sound like science fiction, but DEEP is already making this a reality. With the recent launch of its subsea habitat Vanguard, DEEP is pushing forward with its promise to make humans aquatic. An engineering company pushing the boundaries of what’s possible, DEEP exists to radically advance how humankind can access, explore and inhabit underwater environments. In this episode, Sophie Bushwick speaks to DEEP’s Chief Technology Officer, Norman Smith and Director of Habitat Operations, Roger Garcia. Together they take us on a tour of Vanguard, from its  cosy living area with a viewport to the ocean realm, to the “moon pool” which serves as the entryway into the habitat. They discuss the scientific missions a habitat like this enables - like planet-saving coral reef restoration. And they explore the engineering that’s gone into making this possible, the pressures and joys of life as an “aquanaut” and how it feels to have sea creatures as your neighbours. This is a New Scientist CoLab production, sponsored by DEEP. Your host is Sophie Bushwick. Find out more here. Learn more about your ad choices. Visit megaphone.fm/adchoices

    30 min

  3. 09/17/2025

    Inside the UK’s Energy Revolution

    The UK’s energy system is undergoing a quiet revolution. As we move away from fossil fuels towards a cleaner, more flexible, and electrified future, Octopus Energy is helping to turn the traditional power grid on its head. In this episode of New Scientist CoLab, Justin Mullins is joined by Kieron Stopforth, Head of Flexibility at Octopus Energy.  Kieron explains how the way we generate, store and use electricity is changing - and why your home, solar panels, and even your car could be part of the solution. This is a New Scientist CoLab production, sponsored by Octopus Energy. Your host is Justin Mullins. Find out more at newscientist.com/podcasts. Learn more about your ad choices. Visit megaphone.fm/adchoices

    33 min

  4. 09/11/2025

    A world without dementia? The science and hope ahead

    Dementia is the UK’s leading cause of death, and one in three people born today will develop it in their lifetime. With numbers steadily rising, the need for effective treatments and improved dementia diagnosis is more urgent than ever. Thankfully, recent advances in science mean we understand the diseases that cause dementia better than ever. There has never been a more exciting time in dementia research, and supporting some of the most pioneering work in this field is UK charity Alzheimer’s Society. In this episode of the New Scientist CoLab podcast, Justin Mullins is joined by Richard Oakley, Associate Director of Research and Innovation at Alzheimer's Society. Richard explores the latest breakthroughs in dementia treatment and promising areas of research. He discusses the latest technologies and trials that are bringing us closer to a better future for people living with dementia. And he discusses his belief that research, with time, can beat dementia. This is a New Scientist CoLab production, sponsored by Alzheimer’s Society. Find out more at newscientist.com/podcasts Learn more about your ad choices. Visit megaphone.fm/adchoices

    35 min
  5. How Vertex Pharmaceuticals is revolutionising drug discovery

    09/07/2025

    How Vertex Pharmaceuticals is revolutionising drug discovery

    What does it take to tackle the world’s most complex diseases? For David Price, head of the Vertex Pharmaceuticals Oxford Research site, the motivation is deeply personal. In this podcast from New Scientist CoLab, David shares his incredible journey and gives a detailed look inside Vertex, the company that pioneered patient-first drug discovery. Learn about their unique serial innovation strategy, which focuses on treating the underlying cause of a disease, not just the symptoms. He also discusses how automation and robotics are transforming the lab and why talented students and interns represent an extraordinary future. Sponsored by Vertex Pharmaceuticals. Learn more about your ad choices. Visit megaphone.fm/adchoices

    19 min
  6. Women in Science Episode 3: From the classroom to global defence leader

    07/17/2025

    Women in Science Episode 3: From the classroom to global defence leader

    Hear an inspiring story of career transformation, leadership, and purpose-driven science. In this special series of New Scientist CoLab interviews, we spotlight exceptional women driving progress in science, technology, engineering, and mathematics. Lorna is a Senior Science Manager at AWE, a technology and security organisation supporting the UK's nuclear deterrent. She’s the Acting Group Leader of Defence Radiation Protection Services at AWE, leading a team of 71 specialists. Lorna’s story is a reminder that STEM careers can begin in the most unexpected places as she shares her unconventional journey into science which began not in a laboratory, but in a classroom as a teacher.   We explore: ●      Lorna’s bold career pivot from education to national defence science ●      How she now delivers radiation protection for MOD operations ●      The value of diverse backgrounds in STEM and her path ●      And her advice for others considering non-traditional paths into science and engineering This series is proudly sponsored by AWE. Your host is Claire Aisnworth.   For more podcasts in this series, head to newscientist.com/podcasts Learn more about your ad choices. Visit megaphone.fm/adchoices

    32 min
  7. Women in Science Episode 4: Inside the world of nuclear test monitoring

    07/17/2025

    Women in Science Episode 4: Inside the world of nuclear test monitoring

    Meet a woman who works at the frontlines of global nuclear monitoring. In this special series of New Scientist CoLab interviews, where we spotlight exceptional women driving progress in science, technology, engineering, and mathematics. Jenny is the leader of AWE’s forensic seismology team and Lead UN Inspector for the Comprehensive Nuclear Test Ban Treaty Organisation, which carries out large-scale inspections across the globe. She walks us through everything from what might prompt an inspection to what actually happens on the ground, highlighting just how complex these high-stakes missions are. We explore: ●      Jenny’s pioneering career at the intersection of science, security, and diplomacy ●      What skills are needed to work in high-stakes, global environments ●      Her advice for women looking to make a difference in STEM and international security This series is proudly sponsored by AWE. Your host is Claire Aisnworth. For more podcasts in this series, head to newscientist.com/podcasts Learn more about your ad choices. Visit megaphone.fm/adchoices

    35 min
  8. Women In Science Episode 1 : The engineer behind the UK’s nuclear deterrent

    06/19/2025

    Women In Science Episode 1 : The engineer behind the UK’s nuclear deterrent

    A rare behind-the-scenes look at what it means to lead critical engineering work in one of the most secure and technologically advanced environments in the country.   In this special series of New Scientist CoLab interviews, we spotlight exceptional women driving progress in science, technology, engineering, and mathematics.   This episode is a deep dive into the world of high-stakes engineering, leadership, and innovation at the cutting edge of national security.   Helen is Group Leader for Engineering at AWE, a technology and security organisation supporting the UK's nuclear deterrent. She’s a Member of the Senior Leadership Team for the Astraea Programme, a once-in-a-generation project to develop the UK’s next nuclear warhead.   In this episode we explore:   ●     Helen’s career journey and path to senior leadership ●     The common misconceptions about working in engineering ●     How to balance family-life with a high-security, high-impact role ●     And how AWE is championing diversity, inclusion, and opportunities for women in STEM This series is proudly sponsored by AWE. Your host is Claire Aisnworth.   For more podcasts in this series, head to newscientist.com/podcasts Learn more about your ad choices. Visit megaphone.fm/adchoices

    27 min
See All (14)

About

Podcasts for the insatiably curious, produced by New Scientist in collaboration with carefully selected external parties. Hosted on Acast. See acast.com/privacy for more information.

Information

More From New Scientist